Abstract | PURPOSE: METHODS: We randomised 20 consecutive patients (mean age 4.1 years) with CPT (Crawford type IV) associated with neurofibromatosis type 1(NF1) and no previous history of surgery into two groups. Group 1 received recombinant human bone morphogenetic protein-7 (rhBMP-7) along with intramedullary Kirschner (K)-wire fixation and autologous bone grafting; group 2 received only K wire and grafting. Outcome measures were time to achieve union, Johnston grade, tibial length and the American Orthopaedic Foot and Ankle Society (AOFAS) score, which were evaluated preoperatively and at five year follow-up. RESULTS: Study results showed that patients in group 1 achieved primary bone union at a mean of 14.5 months [standard error (SE) 5.2], whereas group 2 took a mean of 17.11 months (SE 5.0). However, the log-rank test showed no difference in healing times between groups at all time points (P = 0.636). There was a statistically significant pre- to post operative improvement (P < 0.05) within groups for the other outcome measures. CONCLUSION: In a five year follow-up, these results suggest that rh-BMP-7 and autologous bone grafting is no better than autologous grafting alone.
|
Authors | Sakti Prasad Das, Shankar Ganesh, Sudhakar Pradhan, Deepak Singh, Ram Narayan Mohanty |
Journal | International orthopaedics
(Int Orthop)
Vol. 38
Issue 9
Pg. 1987-92
(Sep 2014)
ISSN: 1432-5195 [Electronic] Germany |
PMID | 24827969
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Bone Morphogenetic Protein 7
- Recombinant Proteins
|
Topics |
- Bone Morphogenetic Protein 7
(therapeutic use)
- Bone Transplantation
(methods)
- Bone Wires
- Child
- Child, Preschool
- Female
- Follow-Up Studies
- Fracture Fixation
(instrumentation, methods)
- Fracture Healing
(drug effects)
- Humans
- Male
- Outcome Assessment, Health Care
- Prospective Studies
- Pseudarthrosis
(congenital, therapy)
- Recombinant Proteins
(therapeutic use)
- Tibial Fractures
(congenital, therapy)
- Treatment Outcome
|